Skip to main content
2025 IDWeek Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Session Icons
Live Streamed
Live Streamed
On Demand
On Demand
View Session Discussion + Q&A

Adult ID

Epi & Infection Control

Global ID

Investigative ID

HIV-STD-TB

Pediatric ID

Trainee

Transplant

COVID-19
Session Type: Named Lecture

93 - John F. Enders Lecture

Monday, October 20, 2025
4:45 PM - 6:00 PM US ET
Location: Ballroom (Hall B1)

Live Streamed On Demand
CME Credits: Maximum of .50 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of .50 hours of MOC Credit
CNE Credits: Maximum of .50 hours of ANCC Credit
ACPE Credits: ACPE .50 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

    Moderator(s)

  • ​​​​Tina Q. Tan, MD, FIDSA, FPIDS, FAAP (she/her/hers)

    Pediatric Infectious Diseases Attending, Medical Director International Patient and Destination Services Program, President Lurie Children's Medical Dental Staff; Professor of Pediatrics
    Ann & Robert H. Lurie Childrens' Hospital of Chicago; Northwestern University Feinberg School of Medicine
    Chicago, Illinois, United States

    • Faculty(s)

  • H. Keipp Talbot, MD MPH FIDSA

    Professor
    Vanderbilt University Medical Center

  • ​​​​Tina Q. Tan, MD, FIDSA, FPIDS, FAAP (she/her/hers)

    Pediatric Infectious Diseases Attending, Medical Director International Patient and Destination Services Program, President Lurie Children's Medical Dental Staff; Professor of Pediatrics
    Ann & Robert H. Lurie Childrens' Hospital of Chicago; Northwestern University Feinberg School of Medicine
    Chicago, Illinois, United States

Disclosure(s):
​​​​Tina Q. Tan, MD, FIDSA, FPIDS, FAAP: GSK: Advisor/Consultant, Grant/Research Support; Merck and Company, Inc.: Advisor/Consultant; Moderna, Inc.: Advisor/Consultant; Novavax, Inc.: Advisor/Consultant; Pfizer, Inc.: Advisor/Consultant; Sanofi Pasteur LLC: Advisor/Consultant
H. Keipp Talbot, MD MPH FIDSA: No financial relationships to disclose.

John F. Enders, PhD, served as the second president of IDSA. Dr. Enders and two of his colleagues received the 1954 Nobel Laureate in Medicine for their discovery of the ability to poliomyelitis viruses to grow in cultures of various types of tissue. This discovery led to the development of vaccines against polio, measles, rubella and mumps. His contributions, which include major advances in the field of genetics, links between viruses and cancer, and insights into the pattern and process of tumor growth, are noted among the most important of the 20th century. The John F. Enders Distinguished Lecture in Medical Virology, which bears his name, was first given in 1988 by Thomas Weller, MD.

Presentations:

  • 4:45 PM - 5:20 PM US ET
    Awards Presentation
  • 5:20 PM - 5:45 PM US ET
    Vaccines in the Golden Years

    Speaker: H. Keipp Talbot, MD MPH FIDSA – Vanderbilt University Medical Center

  • 5:45 PM - 6:00 PM US ET
    Standing Together, Protecting Health: IDSA's Call to Action

    Speaker: ​​​​Tina Q. Tan, MD, FIDSA, FPIDS, FAAP (she/her/hers) – Ann & Robert H. Lurie Childrens' Hospital of Chicago; Northwestern University Feinberg School of Medicine